Estimating Risk of Sporadic Colorectal Cancer in Veterans Under Age 50

NIH RePORTER · VA · I01 · · view on reporter.nih.gov ↗

Abstract

 DESCRIPTION (provided by applicant): Identification of risk factors for sporadic colorectal cancer (CRC) and creation of a prediction model for it will help target high-risk persons for early screening. Such targeting may reduce morbidity and mortality from this particularly devastating disease in this very vital age group, an without the need to apply screening broadly to a population where non-targeted screening is likely to cause more harm than good. Screening for CRC is recommended for average-risk persons aged 50 years and older. However, 7-11% of all CRC occurs in persons < 50, most of whom have no classic risk factors at the time of diagnosis. These persons are not only younger, but often present with more advanced disease and have a less favorable prognosis than older persons. During the last 20 years, the incidence of CRC, while falling in persons 50 years old and older, has risen steadily in persons under age 50. For these reasons, it is critically importan to try to identify among Veterans (who are already a high-risk group), those < age 50 at high-risk for CRC, who may be candidates for "early" screening. From a practical perspective, an efficient way to identify Veterans using electronic medical record (EMR) data would facilitate implementation. Project objectives include: 1) Identify risk factors for sporadic (i.e., non-hereditary) CRC in persons < age 50; 2) Derive and validate a prediction model for quantifying absolute and relative risks for CRC; 3) Compare the accuracy of automated data abstraction using natural language processing for identifying and abstracting risk factor information from VA electronic health information to the gold standard of manual electronic medical record review. Using the VA Central Cancer registry, we will identify incident cases of CRC diagnosed between 2008 and 2014. We will verify case eligibility from manual review of CPRS, excluding those with inflammatory bowel disease, a high-risk family history, polyposis syndrome, or hereditary non-polyposis colon cancer syndrome. Using medical SAS datasets, we will match each final case to 4 controls during the same time period and validate the control group by using a second control group with a negative (i.e., no neoplasia) diagnostic colonoscopy. The same exclusions will apply to controls, along with previous colectomy of any extent and for any reason. Cases and controls will be matched for facility. Manual review of EMR in VistAweb will be conducted by trained research personnel, who will identify information about candidate risk factors of lifestyle habits (cigarette and ethanol use, occupation, leisure activity / exercise), family cancer history, BMI, socio-demographic features, certain laboratory test results, prior CRC screening test results, and medication use. Logistic regression will be used to identify independent factors associated with CRC. A prediction model will be derived and internally validated. Age- and gender- specific SEER CR...

Key facts

NIH application ID
10016126
Project number
5I01HX001650-03
Recipient
RLR VA MEDICAL CENTER
Principal Investigator
THOMAS F. IMPERIALE
Activity code
I01
Funding institute
VA
Fiscal year
2020
Award amount
Award type
5
Project period
2016-06-01 → 2020-03-31